Latest Nuvasive Inc (NUVA) Headlines 24.3% Retu
Post# of 51
24.3% Return Seen to Date on SmarTrend NuVasive Call (NUVA)
Comtex SmarTrend(R) - Fri Mar 07, 5:00PM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on October 30th, 2013 at $29.88. In approximately 4 months, NuVasive has returned 24.26% as of today's recent price of $37.13.
Sorrento Therapeutics (SRNE) Soars: Stock Up 8.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 8:39AM CST
Sorrento Therapeutics, Inc. was a big mover last session, as its shares rose nearly 9% on the day.
Stryker Continues Acquisition Spree but Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 05, 4:20PM CST
Since the announcement of both the acquisitions, shares of Stryker declined 1.8% till the last closing day.
Quarterly and Annual Financial Results Release, Executive Appointments, Upcoming Conferences, and Promotion Announcements - Analyst Notes on NuVasive, IPC, Portola, ICU Medical, and Prothena
PR Newswire - Wed Mar 05, 7:32AM CST
Editor Note: For more information about this release, please scroll to bottom.
Balanced View Retained for Boston Scientific - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 04, 2:00PM CST
On Mar 04, 2014, we issued an updated research report on Boston Scientific Corporation.
NuVasive Up After Q4 Beat, Despite Cautious Guidance
at Investor's Business Daily - Tue Mar 04, 11:01AM CST
Shares of spinal-products company NuVasive (NUVA) popped to a nearly four-year high on the stock market today, a day after the firm beat analysts' Q4 profit expectations. In January, NuVasive had already given a preliminary sales number of $189...
NuVasive(R) Management to Participate in Investor Events in March 2014
Marketwire - Tue Mar 04, 7:30AM CST
NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that management will participate in the following investor events in March 2014:
NuVasive Reports Fourth Quarter and Full Year 2013 Financial Results
Marketwire - Mon Mar 03, 3:30PM CST
NuVasive, Inc. (NASDAQ: NUVA)
Ukraine Unrest Sparks Selling But Some Biotechs Firm Up
at Investor's Business Daily - Mon Mar 03, 3:22PM CST
Major averages suffered a setback Monday with closes near lows and losses close to 1%. It's been a while since geopolitical concerns unnerved the market, but Russia's military presence in Ukraine continued to take center stage. The Dow Jones...
Shares of NUVA Up 24.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Feb 28, 11:08AM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on October 30th, 2013 at $29.88. In approximately 4 months, NuVasive has returned 24.80% as of today's recent price of $37.29.
Australia Orthopedic Devices Market Outlook to 2020 Research Report
M2 - Thu Feb 27, 3:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/87r84j/australia) has announced the addition of the "Australia Orthopedic Devices Market Outlook to 2020 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others" report to their offering. Australia Orthopedic Devices Market Outlook to 2020 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Hip Reconstruction, Knee Reconstruction, Shoulder Reconstruction, Small Joint Reconstruction, Orthobiologics, Orthopedic Braces and Supports, Arthroscopy, Cranio Maxillofacial Fixation (CMF), Orthopedic Bone Cement and Casting Materials, Spinal Surgery, Trauma Fixation, Orthopedic Tools and Orthopedic Prosthetics. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the orthopedic devices market wherever available. The data in the report is derived from dynamic market forecast models. The uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size and company share data for Orthopedic Devices market categories - Hip Reconstruction, Knee Reconstruction, Shoulder Reconstruction, Small Joint Reconstruction, Orthobiologics, Orthopedic Braces and Supports, Arthroscopy, Cranio Maxillofacial Fixation (CMF), Orthopedic Bone Cement and Casting Materials, Spinal Surgery, Trauma Fixation, Orthopedic Tools and Orthopedic Prosthetics. - Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the Australia Orthopedic Devices market. Key Topics Covered: List of Tables List of Figures Introduction Orthopedic Devices Market, Australia Arthroscopy Market, Australia Cranio Maxillofacial Fixation (CMF) Market, Australia Hip Reconstruction Market, Australia Knee Reconstruction Market, Australia Orthobiologics Market, Australia Orthopedic Bone Cement and Casting Materials Market, Australia Orthopedic Braces and Supports Market, Australia Orthopedic Prosthetics Market, Australia Orthopedic Tools Market, Australia Other Joint Reconstruction Market, Australia Spinal Surgery Market, Australia Trauma Fixation Market, Australia Overview of Key Companies in Australia Orthopedic Devices Market Orthopedic Devices Market Pipeline Products Financial Deals Landscape Recent Developments Appendix List of Tables List of Figures Companies Mentioned DePuy Companies Zimmer Holdings, Inc. Stryker Corporation Smith & Nephew Plc Biomet, Inc. Medtronic, Inc. Arthrex, Inc. NuVasive, Inc. Otto Bock HealthCare GmbH ConMed Corporation ArthroCare Corporation For more information visit http://www.researchandmarkets.com/research/87r84j/australia About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Greatbatch Q4 Earnings Lag by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 12:20PM CST
Net revenues in the quarter improved 11.0% (13% on an organic constant currency basis) to $176.6 million, which was almost in line with the Zacks Consensus Estimate of $176.0 million
Orthopedic Devices Market Trends and Forecast, 2013-2019: Hip, Knee, Spine, Shoulder, Elbow, Foot and Ankle, Craniomaxillofacial and Other Extremities
M2 - Wed Feb 26, 9:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/8qtn4s/orthopedic) has announced the addition of the "Orthopedic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global orthopedic devices market was valued at USD 29.2 billion in 2012 and is expected to grow at a CAGR of 4.9% from 2013 to 2019, to reach an estimated value of USD 41.2billion in 2019. This report studies the global market for orthopedic devices from the perspective of various anatomical locations in the human body. The market is thus broadly segmented into anatomical locations such as hip, knee, shoulder, elbow, foot and ankle, spine, craniomaxillofacial and other extremities. These anatomical locations are further categorized into joint implants, internal fixation devices and external fixation devices, based on the availability of the products in the market. Geographically, the market is analyzed for four major regions, namely North America, Europe, Asia and Rest of the World (RoW). The market for all these segments is analyzed and estimated in USD million. Each of the segment has been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD million, considering 2011 and 2012 as the base years. The compounded annual growth rate (%CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size. A competitive landscape, mapping all the market players and their respective market shares for 2012 are provided in this report. Some of the major players profiled in this report are aap Implantate AG, Biomet, Inc., Exactech, Inc., Globus Medical, Inc., Integra LifeSciences Corporation, Medtronic, Inc., NuVasive, Inc., Orthofix Holdings, Inc., Inc. Stryker Corporation, Wright Medical Technology, Inc. and Zimmer Holdings, Inc. All these market players are profiled in this report based on various parameters such as company overview, financial overview, business strategies, product portfolio and recent developments. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Orthopedic Devices Market Overview Chapter 4 Global Orthopedic Devices Market, by Anatomical Location, Size and Forecast, 2011-2019 (USD Million) Chapter 5 Global Orthopedic Consumables, Market Revenue, 2011 - 2019 Chapter 6 Global Orthopedic Devices Market, by Geography, Size and Forecast, 2011 - 2019 Value (USD Million) Chapter 7 Competitive Landscape Chapter 8 Recommendations Chapter 9 Company Profiles For more information visit http://www.researchandmarkets.com/research/8qtn4s/orthopedic
New Union Taunts Established Counterpart
by Anthony Langat - All Africa Global Media - Wed Feb 26, 6:46AM CST
MEMBERS of the newly-formed Public Servants Trade Unions (PUSETU) have taunted the Secretary General of the Central Organizations of Trade Unions, Francis Atwoli, to desist from mudslinging the union.
Wright Medical Group Sees Wider Q4 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 9:00AM CST
For full-year 2013, Wright Medical Group posted a wider adjusted loss of $25.2 million or 48 cents per share compared with $3.8 million or 10 cents per share in 2012.
Brookdale Senior Living Up with Emeritus Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 5:00PM CST
The uptick in BKD's price is likely given the expansion of Brookdale's presence in large population states.
Will These 3 Early Stock Winners of 2014 Keep Up Their Good Fortunes?
Dan Carroll, The Motley Fool - Motley Fool - Mon Feb 24, 1:30PM CST
The market has had a rocky first two months of 2014 after last year's astronomical boom, but a few medical device stocks have shaken off the dust to roar to great gains on the year so far. Intuitive Surgical is perhaps the most surprising stock to...
ICU Medical (ICUI) Crumbles: Stock Falls by 6.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 7:42AM CST
ICU Medical saw a big move last session, as the company’s shares fell by nearly 7% on the day
Uptrend Call Working As NuVasive Stock Rises 24.6% (NUVA)
Comtex SmarTrend(R) - Fri Feb 21, 9:43AM CST
SmarTrend identified an Uptrend for NuVasive (NASDAQ:NUVA) on October 30th, 2013 at $29.88. In approximately 4 months, NuVasive has returned 24.56% as of today's recent price of $37.22.
Symmetry Medical Sees In-Line Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 8:30AM CST
For full year 2013, SMA reported a 42.0% fall in adjusted earnings per share to 29 cents from 50 cents in 2012